Abstract
Background: The serological diagnosis of primary Epstein-Barr virus (EBV) infections is often difficult, whereas the relevance of elevated immunoglobulin G (IgG) antibodies against early antigen (EA) for the diagnosis of EBV reactivation has increasingly become a matter of dispute. Recently, EBV PCR has been added as a diagnostic tool. Positive EBV PCR has been demonstrated in the serum of patients with primary EBV infections and EBV reactivation.
Objectives: To compare classical serological diagnosis of primary EBV infection and EBV reactivation with real-time EBV PCR.
Study design: Sera from 45 patients were selected with detectable immunoglobulin M (IgM) antibodies against EBV viral capsid antigen (VCA), and 62 sera were selected with a reactivation profile. A real-time EBV PCR was performed with DNA extracted from these sera.
Results: Based on serological data, the diagnosis of primary EBV infection was established for 24 of the 45 IgM VCA-positive patients. By performing PCR, seven extra cases of primary infection were diagnosed for which no heterophilic antibodies could be detected. In five cases of primary infection, no EBV DNA could be detected by PCR. Only in two of the 62 sera with a reactivation seroprofile could EBV DNA be detected.
Conclusions: Based on these data, we suggest that for the diagnosis of primary infections, EBV PCR could lead to an increase of >16% in the number of positive diagnoses by confirming a positive IgM VCA in the absence of heterophilic antibodies. Furthermore, EBV PCR is positive in only 3% of sera with elevated antibodies against EA, raising doubt as to the utility of EA titers for diagnosing EBV reactivation.
Similar content being viewed by others
References
Grotto I, Mimouni D, Huerta M, et al. Clinical and laboratory presentation of EBV positive infectious mononucleosis in young adults. Epidemiol Infect 2003; 131(1): 683–9
Horwitz CA, Henle W, Henle G, et al. Clinical evaluation of patients with infectious mononucleosis and development of antibodies to the R component of the Epstein-Barr virus-induced early antigen complex. Am J Med 1975; 58(3): 330–8
Tobi M, Morag A, Ravid Z, et al. Prolonged atypical illness associated with serological evidence of persistent Epstein-Barr virus infection. Lancet 1982; I(8263): 61–4
DuBois RE, Seeley JK, Brus I, et al. Chronic mononucleosis syndrome. South Med J 1984; 77(11): 1376–82
Jones JF, Ray CG, Minnich LL, et al. Evidence for active Epstein-Barr virus infection in patients with persistent, unexplained illnesses: elevated anti-early antigen antibodies. Ann Intern Med 1985; 102(1): 1–7
Straus SE, Tosato G, Armstrong G, et al. Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection. Ann Intern Med 1985; 102(1): 7–16
Rea TD, Ashley RL, Russo JE, et al. A systematic study of Epstein-Barr virus serologic assays following acute infection. Am J Clin Pathol 2002; 117(1): 156–61
Uldall A, Jensen BS, Henrichsen J. Kits for the diagnosis of infectious mononucleosis compared with the Paul-Bunnell test. J Clin Chem Clin Biochem 1990; 28(6): 423–5
Rogers R, Windust A, Gregory J. Evaluation of a novel dry latex preparation for demonstration of infectious mononucleosis heterophile antibody in comparison with three established tests. J Clin Microbiol 1999; 37(1): 95–8
Patrascu IV, Ghenoiu O, Tache M. Epstein-Barr virus (EBV): V. Incidence of EBV antibodies in patients with rheumatic diseases. Virologie 1989; 40(1): 25–9
Aalto SM, Linnavuori K, Peltola H, et al. Immunoreactivation of Epstein-Barr virus due to cytomegalovirus primary infection. J Med Virol 1998; 56(3): 186–91
Deyi YM, Goubau P, Bodeus M. False-positive IgM antibody tests for cytomegalovirus in patients with acute Epstein-Barr virus infection. Eur J Clin Microbiol Infect Dis 2000; 19(7): 557–60
Rhodes G, Smith RS, Rubin RE, et al. Identical IgM antibodies recognizing a glycine-alanine epitope are induced during acute infection with Epstein-Barr virus and cytomegalovirus. J Clin Lab Anal 1990; 4(6): 456–64
Horwitz CA, Henle W, Henle G, et al. Long-term serological follow-up of patients for Epstein-Barr virus after recovery from infectious mononucleosis. J Infect Dis 1985; 151(6): 1150–3
Fleisher GR, Collins M, Fager S. Humoral immune response in infectious mononucleosis: late emergence of anti-EA (R) and the effects of corticosteroid therapy. J Adolesc Health Care 1985; 6(6): 424–8
Holmes GP, Kaplan JE, Stewart JA, et al. A cluster of patients with a chronic mononucleosis-like syndrome: is Epstein-Barr virus the cause? JAMA 1987; 257(17): 2297–302
Buchwald D, Sullivan JL, Komaroff AL. Frequency of ‘chronic active Epstein-Barr virus infection’ in a general medical practice. JAMA 1987; 257(17): 2303–7
Hellinger WC, Smith TF, Van Scoy RE, et al. Chronic fatigue syndrome and the diagnostic utility of antibody to Epstein-Barr virus early antigen. JAMA 1988; 260(7): 971–3
Soto NE, Straus SE. Chronic fatigue syndrome and herpesviruses: the fading evidence. Herpes 2000; 7(2): 46–50
Pitetti RD, Laus S, Wadowsky RM. Clinical evaluation of a quantitative real time polymerase chain reaction assay for diagnosis of primary Epstein-Barr virus infection in children. Pediatr Infect Dis J 2003; 22(8): 736–9
Kimura H, Morita M, Yabuta Y, et al. Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay. J Clin Microbiol 1999; 37(1): 132–6
Berger C, Day P, Meier G, et al. Dynamics of Epstein-Barr virus DNA levels in serum during EBV-associated disease. J Med Virol 2001; 64(4): 505–12
Chan KH, Ng MH, Seto WH, et al. Epstein-Barr virus (EBV) DNA in sera of patients with primary EBV infection. J Clin Microbiol 2001; 39(11): 4152–4
Brengel-Pesce K, Morand P, Schmuck A, et al. Routine use of real-time quantitative PCR for laboratory diagnosis of Epstein-Barr virus infections. J Med Virol 2002; 66(3): 360–9
Gan YJ, Sullivan JL, Sixbey JW. Detection of cell-free Epstein-Barr virus DNA in serum during acute infectious mononucleosis. J Infect Dis 1994; 170(2): 436–9
van Esser JW, van der HB, Meijer E, et al. Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell-depleted SCT. Blood 2001; 98(4): 972–8
van Esser JW, Niesters HG, Thijsen SF, et al. Molecular quantification of viral load in plasma allows for fast and accurate prediction of response to therapy of Epstein-Barr virus-associated lymphoproliferative disease after allogeneic stem cell transplantation. Br J Haematol 2001; 113(3): 814–21
Test for infectious mononucleosis. BMJ 1980; 280 (6224): 1153–4
Andiman WA. Diagnostic procedures for viral, rickettsial and chlamydial infections. 6th ed. Washington, DC: American Public Health Association Inc., 1989
Niesters HG, van Esser J, Fries E, et al. Development of a real-time quantitative assay for detection of Epstein-Barr virus. J Clin Microbiol 2000; 38(2): 712–5
Laroche C, Drouet EB, Brousset P, et al. Measurement by the polymerase chain reaction of the Epstein-Barr virus load in infectious mononucleosis and AIDS-related non-Hodgkin’s lymphomas. J Med Virol 1995; 46(1): 66–74
Kimura H, Nishikawa K, Hoshino Y, et al. Monitoring of cell-free viral DNA in primary Epstein-Barr virus infection. Med Microbiol Immunol (Berl) 2000; 188(4): 197–202
Lei KI, Chan LY, Chan WY, et al. Diagnostic and prognostic implications of circulating cell-free Epstein-Barr virus DNA in natural killer/T-cell lymphoma. Clin Cancer Res 2002; 8(1): 29–34
Lei KI, Chan LY, Chan WY, et al. Quantitative analysis of circulating cell-free Epstein-Barr virus (EBV) DNA levels in patients with EBV-associated lymphoid malignancies. Br J Haematol 2000; 111(1): 239–46
van Kooy B, Thijsen SFT, Meijer E, et al. Sequence analysis of EBV DNA isolated from mouth washings and PBMC’s of healthy individuals and blood of EBV-LPD patients. J Clin Virol 2003; 28(1): 85–92
Ohshima K, Suzumiya J, Ohga S, et al. Integrated Epstein-Barr virus (EBV) and chromosomal abnormality in chronic active EBV infection. Int J Cancer 1997; 71(6): 943–7
Ohshima K, Suzumiya J, Kanda M, et al. Integrated and episomal forms of Epstein-Barr virus (EBV) in EBV associated disease. Cancer Lett 1998; 122(1–2): 43–50
Jones MD, Griffin BE. Clustered repeat sequences in the genome of Epstein Banvirus. Nucleic Acids Res 1983; 11(12): 3919–37
Stevens SJ, Pronk I, Middeldorp JM. Toward standardization of Epstein-Barr virus DNA load monitoring: unfractionated whole blood as preferred clinical specimen. J Clin Microbiol 2001; 39(4): 1211-6
Acknowledgements
No sources of funding were used to assist in conducting this study. The authors have no conflicts of interest that are directly relevant to the content of the study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Luderer, R., Kok, M., Niesters, H.G.M. et al. Real-Time Epstein-Barr Virus PCR for the Diagnosis of Primary EBV Infections and EBV Reactivation. CNS Drugs 9, 195–200 (2005). https://doi.org/10.1007/BF03260091
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03260091